The Community Guide

- gsearch

Search Results

All Collections

Morbidity and Mortality Weekly Report (MMWR)

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

Narrow Results:

Volume 73 41

Weekly Report: Morbidity and Mortality Weekly Report (MMWR) 41

2025 2
2024 39

Centers for Disease Control and Prevention (U.S.). 41

Puerto Rico 1
United States 40

Statistics 41
Tables 41

1 - 20 of 41 Results

Refine Results

Refine Results:

Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022

CITE Title : Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 01/02/2025 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2025; v. 73, no. 51 & 52 URL : https://stacks.cdc.gov/view/cdc/174815 Centers for Disease Control and Prevention (U.S.). (2025). Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022. 73 Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022" 73 (2025) Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Frequency and Average Annual Incidence of Tularemia Cases by Demographic Characteristics Overall and Stratified by Case Status — United States, 2011–2022" vol. 73, 2025 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

01/02/2025 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Table. Morbidity and Mortality Weekly Report, Vol. 73, No. 51-52, January 2, 2025
Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022

CITE Title : Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 01/02/2025 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2025; v. 73, no. 51 & 52 URL : https://stacks.cdc.gov/view/cdc/174814 Centers for Disease Control and Prevention (U.S.). (2025). Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022. 73 Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022" 73 (2025) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Average Annual Tularemia Incidence, by Age Group and Sex — United States, 2011–2022" vol. 73, 2025 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

01/02/2025 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Table. Morbidity and Mortality Weekly Report, Vol. 73, No. 51-52, January 2, 2025
Supplementary Figure. Prepositioning and Distribution of Tecovirimat Using a Hub and Spoke Distribution Model — Los Angeles County, California, June 2022–January 2023

CITE Title : Supplementary Figure. Prepositioning and Distribution of Tecovirimat Using a Hub and Spoke Distribution Model — Los Angeles County, California, June 2022–January 2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 06/20/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 24 URL : https://stacks.cdc.gov/view/cdc/157468 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure. Prepositioning and Distribution of Tecovirimat Using a Hub and Spoke Distribution Model — Los Angeles County, California, June 2022–January 2023. 73(24). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Prepositioning and Distribution of Tecovirimat Using a Hub and Spoke Distribution Model — Los Angeles County, California, June 2022–January 2023" 73, no. 24 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Prepositioning and Distribution of Tecovirimat Using a Hub and Spoke Distribution Model — Los Angeles County, California, June 2022–January 2023" vol. 73, no. 24, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

06/20/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 24.
Supplementary Table 2. Estimated Vaccination Coverage by Age 24 Months Among Children Born 2020-2021, by Selected Vaccines and Doses, Poverty Level, and Metropolitan Statistical Area (MSA) Status -- National Immunization Survey-Child, United States, 2021-2023

CITE Title : Supplementary Table 2. Estimated Vaccination Coverage by Age 24 Months Among Children Born 2020-2021, by Selected Vaccines and Doses, Poverty Level, and Metropolitan Statistical Area (MSA) Status -- National Immunization Survey-Child, United States, 2021-2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 09/26/2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 38 URL : https://stacks.cdc.gov/view/cdc/162214 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table 2. Estimated Vaccination Coverage by Age 24 Months Among Children Born 2020-2021, by Selected Vaccines and Doses, Poverty Level, and Metropolitan Statistical Area (MSA) Status -- National Immunization Survey-Child, United States, 2021-2023. 73(38). Centers for Disease Control and Prevention (U.S.). "Supplementary Table 2. Estimated Vaccination Coverage by Age 24 Months Among Children Born 2020-2021, by Selected Vaccines and Doses, Poverty Level, and Metropolitan Statistical Area (MSA) Status -- National Immunization Survey-Child, United States, 2021-2023" 73, no. 38 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table 2. Estimated Vaccination Coverage by Age 24 Months Among Children Born 2020-2021, by Selected Vaccines and Doses, Poverty Level, and Metropolitan Statistical Area (MSA) Status -- National Immunization Survey-Child, United States, 2021-2023" vol. 73, no. 38, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

09/26/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 38
Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024

CITE Title : Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 09/26/2024 Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 38 URL : https://stacks.cdc.gov/view/cdc/162445 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024. 73(38). Centers for Disease Control and Prevention (U.S.). "Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024" 73, no. 38 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table 2. Demographic Characteristics and Clinical Outcomes of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Maternal Vaccination Status, Excluding Birth Hospitalizations — COVID-NET, 12 States, October 2022–April 2024" vol. 73, no. 38, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

09/26/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 38
Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024

CITE Title : Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 09/26/2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 38 URL : https://stacks.cdc.gov/view/cdc/162444 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024. 73(38). Centers for Disease Control and Prevention (U.S.). "Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024" 73, no. 38 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table 1. Demographic Characteristics, Clinical Outcomes, and Maternal Vaccination Status of Infants Aged <6 Months Hospitalized with Laboratory-confirmed SARS-CoV-2 by Birth Hospitalization Status — COVID-NET, 12 States, October 2022–April 2024" vol. 73, no. 38, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

09/26/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 38
Supplementary Table 1. Estimated Vaccination Coverage by Age 24 Months Among Children Born During 2020-2021, by Selected Vaccines and Doses and Health Insurance Status -- National Immunization Survey-Child, United States, 2021-2023

CITE Title : Supplementary Table 1. Estimated Vaccination Coverage by Age 24 Months Among Children Born During 2020-2021, by Selected Vaccines and Doses and Health Insurance Status -- National Immunization Survey-Child, United States, 2021-2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 09/26/2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 38 URL : https://stacks.cdc.gov/view/cdc/162213 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table 1. Estimated Vaccination Coverage by Age 24 Months Among Children Born During 2020-2021, by Selected Vaccines and Doses and Health Insurance Status -- National Immunization Survey-Child, United States, 2021-2023. 73(38). Centers for Disease Control and Prevention (U.S.). "Supplementary Table 1. Estimated Vaccination Coverage by Age 24 Months Among Children Born During 2020-2021, by Selected Vaccines and Doses and Health Insurance Status -- National Immunization Survey-Child, United States, 2021-2023" 73, no. 38 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table 1. Estimated Vaccination Coverage by Age 24 Months Among Children Born During 2020-2021, by Selected Vaccines and Doses and Health Insurance Status -- National Immunization Survey-Child, United States, 2021-2023" vol. 73, no. 38, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

09/26/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 38
Supplementary Figure. Estimated Coverage with Selected Vaccine Doses by Age 24 Months, by Birth Year — National Immunization Survey-Child, United States, 2012–2023

CITE Title : Supplementary Figure. Estimated Coverage with Selected Vaccine Doses by Age 24 Months, by Birth Year — National Immunization Survey-Child, United States, 2012–2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 09/26/2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 38 URL : https://stacks.cdc.gov/view/cdc/162212 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure. Estimated Coverage with Selected Vaccine Doses by Age 24 Months, by Birth Year — National Immunization Survey-Child, United States, 2012–2023. 73(38). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Estimated Coverage with Selected Vaccine Doses by Age 24 Months, by Birth Year — National Immunization Survey-Child, United States, 2012–2023" 73, no. 38 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Estimated Coverage with Selected Vaccine Doses by Age 24 Months, by Birth Year — National Immunization Survey-Child, United States, 2012–2023" vol. 73, no. 38, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

09/26/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 38
Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024

CITE Title : Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 09/26/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 38 URL : https://stacks.cdc.gov/view/cdc/162443 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024. 73(38). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024" 73, no. 38 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure. Cumulative COVID-19–associated Hospitalization Rates by Age Group — Coronavirus Disease 2019–Associated Hospitalization Surveillance Network, 12 States, October 1, 2023–April 30, 2024" vol. 73, no. 38, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

09/26/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

MMWR Supplementary Materials Volume 73; No 38
COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures]

CITE Title : COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures] Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/03/2024 Pages in Document : 2 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 39 URL : https://stacks.cdc.gov/view/cdc/162446 Centers for Disease Control and Prevention (U.S.). (2024). COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures]. 73(39). Centers for Disease Control and Prevention (U.S.). "COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures]" 73, no. 39 (2024) Centers for Disease Control and Prevention (U.S.). "COVID-19–Associated Hospitalizations Among U.S. Adults Aged ≥18 Years — COVID-NET, 12 States, October 2023–April 2024 [2 Supplemental Figures]" vol. 73, no. 39, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/03/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure 1. Percentage of COVID-19–Associated Hospitalizations Among Adults Aged ≥18 Years, by Week and Age Group — COVID-NET, 12 St...
Supplementary Table. Kindergarten Population, Number and Percent Surveyed, and Estimated Number and Percentage of Children with an Exemption by Type of Exemption From Vaccination Among Kindergartners, by Jurisdiction — United States, * 2023–24 School Year

CITE Title : Supplementary Table. Kindergarten Population, Number and Percent Surveyed, and Estimated Number and Percentage of Children with an Exemption by Type of Exemption From Vaccination Among Kindergartners, by Jurisdiction — United States, * 2023–24 School Year Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/17/2024 Pages in Document : 4 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 41 URL : https://stacks.cdc.gov/view/cdc/164305 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table. Kindergarten Population, Number and Percent Surveyed, and Estimated Number and Percentage of Children with an Exemption by Type of Exemption From Vaccination Among Kindergartners, by Jurisdiction — United States, * 2023–24 School Year. 73(41). Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Kindergarten Population, Number and Percent Surveyed, and Estimated Number and Percentage of Children with an Exemption by Type of Exemption From Vaccination Among Kindergartners, by Jurisdiction — United States, * 2023–24 School Year" 73, no. 41 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Kindergarten Population, Number and Percent Surveyed, and Estimated Number and Percentage of Children with an Exemption by Type of Exemption From Vaccination Among Kindergartners, by Jurisdiction — United States, * 2023–24 School Year" vol. 73, no. 41, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/17/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Table. Morbidity and Mortality Weekly Report, Vol. 73, No. 41, October 17, 2024
Supplementary Figure 1. Change in Percentage of Kindergartners Who Are Fully Vaccinated with Measles, Mumps, and Rubella Vaccine (A), Diphtheria, Tetanus, and Acellular Pertussis Vaccine (B), Poliovirus Vaccine (C), and Varicella Vaccine (D) by State — United States, 2022–2023 to 2023–2024 School Years

CITE Title : Supplementary Figure 1. Change in Percentage of Kindergartners Who Are Fully Vaccinated with Measles, Mumps, and Rubella Vaccine (A), Diphtheria, Tetanus, and Acellular Pertussis Vaccine (B), Poliovirus Vaccine (C), and Varicella Vaccine (D) by State — United States, 2022–2023 to 2023–2024 School Years Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/17/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 41 URL : https://stacks.cdc.gov/view/cdc/164303 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure 1. Change in Percentage of Kindergartners Who Are Fully Vaccinated with Measles, Mumps, and Rubella Vaccine (A), Diphtheria, Tetanus, and Acellular Pertussis Vaccine (B), Poliovirus Vaccine (C), and Varicella Vaccine (D) by State — United States, 2022–2023 to 2023–2024 School Years. 73(41). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 1. Change in Percentage of Kindergartners Who Are Fully Vaccinated with Measles, Mumps, and Rubella Vaccine (A), Diphtheria, Tetanus, and Acellular Pertussis Vaccine (B), Poliovirus Vaccine (C), and Varicella Vaccine (D) by State — United States, 2022–2023 to 2023–2024 School Years" 73, no. 41 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 1. Change in Percentage of Kindergartners Who Are Fully Vaccinated with Measles, Mumps, and Rubella Vaccine (A), Diphtheria, Tetanus, and Acellular Pertussis Vaccine (B), Poliovirus Vaccine (C), and Varicella Vaccine (D) by State — United States, 2022–2023 to 2023–2024 School Years" vol. 73, no. 41, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/17/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 41, October 17, 2024
Supplementary Figure 2. Change in Percentage of Kindergartners Exempt From ≥1 Vaccine — United States 2022–2023 to 2023–2024 School Years

CITE Title : Supplementary Figure 2. Change in Percentage of Kindergartners Exempt From ≥1 Vaccine — United States 2022–2023 to 2023–2024 School Years Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/17/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 41 URL : https://stacks.cdc.gov/view/cdc/164304 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure 2. Change in Percentage of Kindergartners Exempt From ≥1 Vaccine — United States 2022–2023 to 2023–2024 School Years. 73(41). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 2. Change in Percentage of Kindergartners Exempt From ≥1 Vaccine — United States 2022–2023 to 2023–2024 School Years" 73, no. 41 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 2. Change in Percentage of Kindergartners Exempt From ≥1 Vaccine — United States 2022–2023 to 2023–2024 School Years" vol. 73, no. 41, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/17/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 41, October 17, 2024
Supplementary Figure.Cases of Acute Flaccid Paralysis Caused by Circulating Vaccine−derived Poliovirus, by Month and Serotype (N = 2,241) — Worldwide, January 2021–June 2024

CITE Title : Supplementary Figure.Cases of Acute Flaccid Paralysis Caused by Circulating Vaccine−derived Poliovirus, by Month and Serotype (N = 2,241) — Worldwide, January 2021–June 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/17/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 41 URL : https://stacks.cdc.gov/view/cdc/164302 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure.Cases of Acute Flaccid Paralysis Caused by Circulating Vaccine−derived Poliovirus, by Month and Serotype (N = 2,241) — Worldwide, January 2021–June 2024. 73(41). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure.Cases of Acute Flaccid Paralysis Caused by Circulating Vaccine−derived Poliovirus, by Month and Serotype (N = 2,241) — Worldwide, January 2021–June 2024" 73, no. 41 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure.Cases of Acute Flaccid Paralysis Caused by Circulating Vaccine−derived Poliovirus, by Month and Serotype (N = 2,241) — Worldwide, January 2021–June 2024" vol. 73, no. 41, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/17/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 41, October 17, 2024
Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023

CITE Title : Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/24/2024 Pages in Document : 3 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 42 URL : https://stacks.cdc.gov/view/cdc/165773 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023. 73(42). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023" 73, no. 42 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 2. Comparison of Proportions of Omicron Lineage XBB.1.5 (a) and HV.1 (B) With 95% CIs, Nationally and by U.S. Department of Health and Human Services Regions 1–10, Estimated With COVID-19 Electronic Reporting and National Respiratory and Enteric Virus Surveillance System–Derived Weights Versus National Respiratory and Enteric Virus Surveillance System Alone — United States, May 14, 2023–November 11, 2023" vol. 73, no. 42, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/24/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 42, October 24, 2024
Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024

CITE Title : Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/24/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 42 URL : https://stacks.cdc.gov/view/cdc/165774 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024. 73(42). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024" 73, no. 42 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 3. Estimated Variant Proportions With 95% Confidence Intervals During the First 14 Weeks of Each Variant’s Emergence (From the Time of Exceeding 1% of National Circulating Viruses) for SARS-CoV-2 Variants Reaching Predominance (>50% Prevalence) — United States, June 2021–September 2024" vol. 73, no. 42, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/24/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 42, October 24, 2024
Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024

CITE Title : Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/24/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 42 URL : https://stacks.cdc.gov/view/cdc/165772 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024. 73(42). Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024" 73, no. 42 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Figure 1. Weekly Counts of Sequences Generated By or Submitted to CDC From the National SARS-CoV-2 Strain Surveillance Program, Contract Commercial Laboratories, and Public Sequence Data Repositories — United States, June 1, 2022–September 14, 2024" vol. 73, no. 42, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/24/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 42, October 24, 2024
Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024

CITE Title : Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/24/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 42 URL : https://stacks.cdc.gov/view/cdc/165771 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024. 73(42). Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024" 73, no. 42 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Voyage Timeframes and Regions of Travel for Patients With Confirmed and Probable Legionnaires Disease — Cruise Ships A and B, 2022–2024" vol. 73, no. 42, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/24/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

No Description
Supplementary Table. Estimated Vaccination Coverage, by World Health Organization Region, Vaccine, and Dose in Series — Worldwide, 2023

CITE Title : Supplementary Table. Estimated Vaccination Coverage, by World Health Organization Region, Vaccine, and Dose in Series — Worldwide, 2023 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/31/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 43 URL : https://stacks.cdc.gov/view/cdc/166709 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table. Estimated Vaccination Coverage, by World Health Organization Region, Vaccine, and Dose in Series — Worldwide, 2023. 73(43). Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Estimated Vaccination Coverage, by World Health Organization Region, Vaccine, and Dose in Series — Worldwide, 2023" 73, no. 43 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Estimated Vaccination Coverage, by World Health Organization Region, Vaccine, and Dose in Series — Worldwide, 2023" vol. 73, no. 43, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/31/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Table. Morbidity and Mortality Weekly Report, Vol. 73, No. 43, October 31, 2024
Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season

CITE Title : Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.). Published Date : 10/31/2024 Pages in Document : 1 pdf page Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 43 URL : https://stacks.cdc.gov/view/cdc/166705 Centers for Disease Control and Prevention (U.S.). (2024). Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season. 73(43). Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season" 73, no. 43 (2024) Centers for Disease Control and Prevention (U.S.). "Supplementary Table. Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season" vol. 73, no. 43, 2024 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.).

10/31/2024 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Supplementary Figure. Morbidity and Mortality Weekly Report, Vol. 73, No. 43, October 31, 2024

1 - 20 / 41

1 2 3